Frequently Asked Questions About Genmab AS (GMAB) Stock
Genmab AS's (GMAB) last reported annual revenue was USD 16.47 Billion.
Genmab AS's (GMAB) annual revenue growth rate based on the revenue reported in the past 5 years is : 40.35%
Genmab AS's(GMAB) is profitable as of its last reported annual financials.
The net profit margin for Genmab AS's(GMAB) from its laster reported year is 26.42%
The return on equity (ROE) for Genmab AS's(GMAB) from its last reported annual financials is : N/A
The return on assets (ROA) for Genmab AS's(GMAB) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for Genmab AS's(GMAB) from its last reported annual financials is : N/A
The Debt to Equity ratio for Genmab AS's(GMAB) from its last reported annual financials is : N/A
The dividend yield for Genmab AS's(GMAB) from its laster reported year is N/A
Genmab AS's(GMAB) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GMAB !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
